RE: How does Omega look with Covid Diagnostics?30 Jan 2022 08:58
Problem they have now with Alva is they have massive capacity but not much make - CD4 and Food Intolerance are the only things selling, but low volumes.
ABC-19 - who knows, ABDX have been ramping it like crazy on Twitter and I suspect their is a demand but will govt allow it? Maybe a tie up with DAM on this?
Visitect is still stuck in the long grass waiting endlessly for approvals?
Maybe this week we will get some clarity on the direction - hoping the placing won’t happen at 5p - that shows how badly things have been ran.
Thing to remember is that no BOD member has lost any money personally in all of this, only the PI’s. Says it all really - as long as they keep the lights on, they can keep coining the money.